IPO Price History
Closed
Remus Pharmaceuticals Limited logo

Remus Pharmaceuticals Limited IPO

SME IPOListedREMUSNSE
Current Market Price (CMP)
₹1,911.30(+55.52%)
Current Price (CMP)
₹1,911.30(+55.52%)

Live Market Quote

Listing Price & Gain
₹213.90(-82.60%)

Day 1 Exchange Open

IPO Issue Price
₹1,229

Band: ₹1150

Total Subscription
57.21x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
17 May 2023
IPO Bidding Closes
19 May 2023
Allotment & Refunds
Completed
Exchange Listing Day
29 May 2023

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 57.21x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)—
Non-Institutional Investors (NII / HNI)—
Retail Individual Investors (RII)—
Total Subscription57.21x
Updated as on null

Listing Day & Return Performance

Listing Day Gain-82.60%
₹1,229 (Issue) → ₹213.90 (List)
Per share profit: ₹-1015.10
Holding Return (Till Date)+55.52%
₹1,229 (Issue) → ₹1,911.30 (CMP)
Net gain per share: +₹682.30
Post-Listing Performance (Listing Day → Today):+793.55%

About Remus Pharmaceuticals Limited IPO

Remus Pharmaceuticals Limited is an Indian public offering categorized under the SME (Small and Medium Enterprise) segment. The public issue opened for bidding on 17 May 2023 and concluded on 19 May 2023, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹1150.

During the bidding window, Remus Pharmaceuticals Limited witnessed heavy demand with an overall subscription of 57.21 times. Institutional investors (QIB) subscribed —, non-institutional high-net-worth investors (NII) subscribed —, and retail individual investors (RII) bid — their reserved quota.

The equity shares of Remus Pharmaceuticals Limited officially debuted on the stock exchanges on 29 May 2023 at an opening listing price of ₹213.90, delivering a listing day return of -82.60% (discount) over the final issue price. As per the latest market data, the stock trades at ₹1,911.30, representing an overall gain of +55.52% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Remus Pharmaceuticals Limited IPO?
The issue price of Remus Pharmaceuticals Limited IPO was fixed at ₹1,229 per equity share. The indicative bidding price band was ₹1150.
What were the open, close, and listing dates for Remus Pharmaceuticals Limited IPO?
Remus Pharmaceuticals Limited IPO opened on 17 May 2023, closed on 19 May 2023, listed on 29 May 2023.
How much was Remus Pharmaceuticals Limited IPO subscribed?
The IPO received an overall subscription of 57.21 times. Category-wise, QIBs subscribed —x, NIIs subscribed —x, and Retail investors subscribed —x.
What was the listing price and listing gain of Remus Pharmaceuticals Limited IPO?
Remus Pharmaceuticals Limited IPO listed on the stock exchange at ₹213.90, delivering a listing discount of 82.60% compared to the IPO issue price of ₹1,229.
Is Remus Pharmaceuticals Limited IPO a Mainboard or SME IPO?
Remus Pharmaceuticals Limited IPO is a SME IPO listed on the SME platform of NSE.
What is the current return of Remus Pharmaceuticals Limited IPO since its IPO?
At the latest market quote of ₹1,911.30, Remus Pharmaceuticals Limited IPO has generated an all-time return of +55.52% since its initial public offering.

Related SME IPOs (2023)

TECHLABS
Trident Techlabs Limited
₹35+180.43%
INDIFRA
Indifra Limited
₹65+10.77%
SUPREMEPWR
Supreme Power Equipment Limited
₹65+50.77%
EFORCE
Electro Force (India) Limited
₹93+7.53%